Cite
MLA Citation
Einat Ritter et al.. “Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease.” Journal of clinical gastroenterology, vol. 55, no. 9, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100174361126.0x00001f